Stocks and Investing Stocks and Investing
Fri, June 4, 2021
[ 12:00 AM ] - WOPRAI
Matthew Sykes Initiated (TWST) at Hold and Held Target at $110 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Sykes Initiated (AVTR) at Strong Buy and Held Target at $40 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Weston Twigg Maintained (AVGO) at Buy with Increased Target to $57 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Blayne Curtis Maintained (AVGO) at Buy with Increased Target to $53 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Aaron Rakers Maintained (AVGO) at Hold with Increased Target to $48 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Hans Mosesmann Maintained (AVGO) at Strong Buy with Increased Target to $55 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Craig Hettenbach Maintained (AVGO) at Buy with Increased Target to $56 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Vijay Rakesh Maintained (AVGO) at Strong Buy with Increased Target to $52 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Ross Seymore Maintained (AVGO) at Strong Buy with Increased Target to $53 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Danely Maintained (AVGO) at Strong Buy with Increased Target to $53 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael Lewis Downgraded (AVB) to Hold on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Fein Initiated (TARA) at Strong Buy and Held Target at $40 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Scott Group Downgraded (ARCB) to Hold on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Anthony Powell Maintained (APLE) at Hold with Increased Target to $17 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Steve Enders Maintained (ASAN) at Buy with Increased Target to $48 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (ASAN) at Buy with Increased Target to $52 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (ASAN) at Buy with Increased Target to $50 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (ASAN) at Buy with Increased Target to $45 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (ASAN) at Hold with Increased Target to $37 on, Jun 4th, 2021
[ 12:00 AM ] - WOPRAI
Jared Shaw Downgraded (ASB) to Hold and Held Target at $24 on, Jun 4th, 2021
Thu, June 3, 2021
[ 12:00 AM ] - WOPRAI
Karl Shepard Maintained (ASB) at Hold with Increased Target to $24 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jack Andrews Maintained (AI) at Strong Buy with Decreased Target to $146 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (AI) at Buy with Decreased Target to $98 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Sanjit Singh Maintained (AI) at Sell with Increased Target to $62 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (AI) at Hold with Decreased Target to $75 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Patrick Colville Maintained (AI) at Hold with Decreased Target to $63 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (AI) at Buy with Decreased Target to $100 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Stephen Baxter Maintained (AGL) at Buy with Increased Target to $44 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Haendel St. Juste Upgraded (AVB) to Strong Buy and Held Target at $231 on, Jun 3rd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (AVIR) at Buy with Decreased Target to $35 on, Jun 3rd, 2021

Matthew Harrison Maintained (AVIR) at Buy with Decreased Target to $35 on, Jun 3rd, 2021


Published on 2024-10-27 16:53:31 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Buy with Decreased Target from $82 to $35 on, Jun 3rd, 2021.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources